Current liabilities increased 29.4%
Current liabilities changed +29.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +29.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +17.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -596 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -322 basis points from the comparable as-filed period.
Shares outstanding changed +18.9% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Operating income changed -55.8% from the comparable as-filed period.
Free-cash-flow proxy changed -61.6% from the comparable as-filed period.
Inventory changed +14.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -42.7% from the comparable as-filed period.
Research & development changed +69.4% from the comparable as-filed period.
Reported total debt changed +41.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross debt changed +41.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Capex / revenue changed +887 basis points from the comparable as-filed period.
Inventory / revenue changed +655 basis points from the comparable as-filed period.
Stock-based compensation changed +75.7% from the comparable as-filed period.
Gross margin changed +160 basis points from the comparable as-filed period.
Selling, general & administrative changed +29.0% from the comparable as-filed period.
Capital expenditure changed +110.5% from the comparable as-filed period.
Cash / debt changed -10167 basis points from the comparable as-filed period.
Debt / revenue changed +840 basis points from the comparable as-filed period.
R&D / revenue changed +404 basis points from the comparable as-filed period.
Operating cash flow / net income changed +75.2% from the comparable as-filed period.
Net debt changed +21.9% from the comparable as-filed period.
Working capital changed -10.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
SBC / revenue changed +179 basis points from the comparable as-filed period.
Free-cash-flow margin changed -874 basis points from the comparable as-filed period.
Current assets changed +8.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Revenue changed -0.2% from the comparable as-filed period.
Gross profit changed +8.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -15.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed +0.4% from the comparable as-filed period.
Debt / assets changed +86 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Trade receivables changed -1.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -2.4% from the comparable as-filed period.
Receivables / revenue changed -21 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed -2.1% from the comparable as-filed period.
Operating cash-flow margin changed +13 basis points from the comparable as-filed period.
Shares outstanding changed +22.4% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Current liabilities changed +18.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +15.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -56.9% from the comparable as-filed period.
Operating margin changed -269 basis points from the comparable as-filed period.
Operating cash flow changed +84.9% from the comparable as-filed period.
Research & development changed +49.2% from the comparable as-filed period.
Revenue changed +25.5% from the comparable as-filed period.
Net debt changed +29.2% from the comparable as-filed period.
Reported total debt changed +54.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed +141.8% from the comparable as-filed period.
Gross debt changed +54.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed +986 basis points from the comparable as-filed period.
Stock-based compensation changed +81.3% from the comparable as-filed period.
Selling, general & administrative changed +45.1% from the comparable as-filed period.
Inventory / revenue changed -1606 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -847.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed +26.1% from the comparable as-filed period.
Operating cash-flow margin changed +534 basis points from the comparable as-filed period.
Cash / debt changed -11500 basis points from the comparable as-filed period.
Operating cash flow / net income changed +94.5% from the comparable as-filed period.
Debt / revenue changed +515 basis points from the comparable as-filed period.
Gross profit changed +22.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -259 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -452 basis points from the comparable as-filed period.
Current assets changed +12.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital / assets changed -177 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
SBC / revenue changed +125 basis points from the comparable as-filed period.
Gross margin changed -41 basis points from the comparable as-filed period.
Net income changed -4.9% from the comparable as-filed period.
Working capital changed +7.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed +133 basis points from the comparable as-filed period.
Debt / assets changed +131 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed -5.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -4.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Trade receivables changed +6.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed -2.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.